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dilated CMP(APD95)
can. 10-4 M 10-3 M
Intramural Heparin (ug)
3.70 ± 3.69
0.57 ± 0.82
0.13 ± 0.16
0.02 ± 001
Time of Harvest
Immediate
30 minutes
60 minutes
24 hours
ischemic CMP (APD95)
can. 10-4 M 10-3 M
Endo
0.5 HZ 304 ± 18 425 ± 26' 559 ± 23' 297 ± 17 390 ± 20' 457 ± 21'
1.0 HZ 274 ± 17 392 ± 18' 519 ± 27* 255 ± 21 383 ± 19' 405 ± 22'
Epi
0.5 HZ 280 ± 14 368 ± 19' 471 ± 20' 277 ± 17 371 ± 18' 419 ± 23'
10 HZ 250 ± 16 350 ± 20' 435 ± 18' 240 ± 13 367 ± 15' 388 ± 15'
Number of Vessels
4
4
4
4
'p < 0.05 Can. vs. d-Sot
Conclusion: D-Sotalol exhibits highly selective class-III activity under all
studied conditions. The parameters of repolarization were differentially af-
fected in the epicardial and endocardial structures with a maximum effect in
the CAD endocardium. The heterogeneity of the endolepi repolarization pat-
terns was markedly more pronounced in ischemic than in dilated cardiomy-
opathy implying enhanced antiarrhythmic as well as proarrhythmic potential
in chronic ischemic myocardium.
Conclusions: Heparin can be safely delivered to coronary angioplasty sites
using iontophoresis. Although subsequent drug washout occurs rapidly,
small amounts of intramural heparin delivered with this technique persist
for at least 24 hours.
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Local Intracoronary Delivery of Heparin and of a
Somatostatin Analogue (Octreotide) Following
Angioplasty in Man: Evaluation of Efficacy of Delivery
by Radio-Isotopic Technique
Local Intracoronary Delivery
In 37 patients (28 men, 58 ± 10 years) following conventional PTCA heparin
(H) (n = 37) and Octreotide (0) (n = 10) was infused through the Dispatch '"
(Scimed) at the site of angioplasty. Mean drug infusion time was 30 ± 7 min
(range: 7-39 min). Avolume of 16 ± 6 ml (range: 1.4-23.4 mil corresponding
to 1660 ± 656 IU Hand 0.39 ± 0.02 I'-g 0 was infused with a mean pres-
sure of 110 ± 48 mmHg. Radio-isotopic studies with infusion of technetium
labelled H (Tc-99m H; n = 2) or of indium labelled 0 (In-111 0; n = 5) were
performed to assess efficacy of local drug delivery. During infusion a linear
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Previous work by our laboratory has demonstrated successful local deliv-
ery of heparin at angioplasty sites with a novel iontophoresis catheter which
uses an applied electric field to selectively move charged drug molecules
into the arterial wall. In order to assess the safety and efficiency of this
technique in the local delivery of heparin in the coronary vasculature, ion-
tophoresis of 3H-heparin was performed in 16 coronary arteries in 7 anes-
thetized pigs. All vessels initially underwent conventional balloon angioplasty
for 60 seconds at 6 atm using standard angioplasty catheters with a balloon-
artery ratio of 1.1 :1. Iontophoresis at 5 mA was then performed with a similar
sized catheter using a heparin concentration of 1000 U/ml, an iontophoretic
membrane balloon pressure of 1 atm, and an iontophoresis time of 90 secs.
Vessels were subsequently harvested at various times up to 24 hours and
counted in a scintillation counter to quantitate intramural heparin deposition
and wash-out.
Results: Heparin iontophoresis in all16 vessels was well tolerated without
change in systemic blood pressure, cardiac rhythm, or coronary angiography.
Intramural drug levels are listed below:
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Heterogenous Repolarization Parameters in Human
Endo- and Epicardial Tissue After Application of
Class-III Agent d-Sotalol in Ischemic and Dilated
Cardiomypathy
Harald Marschang, Thorsten Beyer, Maria Montero, Wolfgang Kubler,
Johannes Brachmann. Department of Cardiology, University of Heidelberg, Germany
Proarrhythmic effects are known as the major limiting factors of antiarrhyth-
mic drug therapy. In class-III compounds proarrhythmia mostly manifests as
Torsade de pointes tachyarrhythmia correlated with EADs and other non-
specific ventricular arrhythmias. The precise underlying mechanism of this
phenomenon and its possible modulation in different pathologic conditions
is still unclear. Intracellular action potentials were recorded by standard mi-
croelectrode techniques from the endo- and epicardial surface of human
myocardial specimens obtained from explanted hearts of patients with is-
chemic and dilated cardiomyopathy undergoing orthotopic heart transplant.
The following electrophysiological parameters were registered: AP ampli-
tude (APA), resting membrane potential (RMP), AP duration at 95% and 50%
repolarization (APD 95 and 50), maximal upstroke velocity (Vmax ) and effec-
tive refractory period (ERP). Values are expressed as mean ± SO.
William J. Groh, James G. Maylie Oregon Health Sciences University, Portland, OR
Myocardial stretch has been shown to shorten action potential duration
(APD) and thus may modulate the efficacy of class III antiarrhythmic agents.
We studied the effect of hypotonic-induced stretch on guinea pig ventricu-
lar myocytes treated with the d-sotalol analogue, E-4031, using a whole-cell
patch clamp technique.
Methods: Myocytes were perfused with normal Tyrode solution [300
mOsmollil at 23°C and dialyzed with a pipette containing (mM): K-Asp 90,
KCI40, NaCI10, MgCI2 1, MgATP 5, HEPES 10, EGTA 10, CaCI2 1, pH 7.1
[310 mOsmolll].
Results: Addition of 10 ILM E-4031 prolonged the APD by 10.1 ± 1.8%
(mean ± SEM), n = 10, P < 0.001. Perfusion with hypotonic (hT) solution [Ty-
rode less 35 mM NaCl, 230 mOsmolli1 + 10 ILM E-4031 induced cell swelling
with width increasing by 38.7 ± 2.7% and length by 6.0 ± 0.7 measured at 5
min, n = 36, p < 0.001. The APD measured at 5 min shortened in hT solution
by 38.7 ± 2.7%, n = 10, p < 0.001. Voltage-clamp studies showed no sig-
nificant change in the Na+, Ca2+, or inward rectifier K+ currents. The slow
component of the delayed rectifier K+ current (lKs) measured during a 5 s de-
polarization to 60 mV increased in hT solution by 31.4 ± 8.2% from 8.2 ± 1.1
pNpF to 10.4 ± 2.5 pNpF, n = 10, P < 0.001. Addition of 10 ILM azimilide
(NE-10064), a potent blocker of IKs ' inhibited the time-dependent outward
current at 60 mV by 82.0 ± 5.3%, n = 10, p = 0.002. The initial current at 60
mV was increased in hT solution by 4.1 ± 2.2 pNpF. This initial current was
partially inhibited by the CI- channel blocker, DIDS, and was not effected by
10 ILM azimilide. In CI--free hT solutions, IKs increased to a similar degree
as in CI--containing solutions (46.8 ± 16.8%, n = 4, p = 0.05). No increase
in the initial current was observed in CI- -free hT solutions.
Conclusions: Hypotonic-induced stretch upregulates IKs and a CI- current
and underlies the APD shortening which occurs with stretch. The increase
in these repolarizing currents with stretch antagonizes the APD prolonging
effect of the d-sotalol analogue, E-4031.
reached 5.6 ± 1.3 and 4.4 ± 0.7 mV for Groups 1-2, respectively (CL 990
ms). After 10 min exposure to E or 0, DAD amplitude increased to 6.6 ± 1.3
and 6.5 ± 1.0 mY, respectively (p < 0.05). In Group 3, after switching from
AS to no drug for 10 min, DAD amplitude was decreased by 2.2 ± 0.5 mV (p
< 0.05). Similar findings were obtained at the 690 ms CL. 2) E and 0 exerted
a biphasic effect on APD, initially shortening it at 10 min of exposure (p <
0.05) before it lengthened. 3) E and 0 prolonged DAD disappearance time
(36.0 ± 2.4, 34.0 ± 8.7, and 16.0 ± 2.4 min in Groups 1-3, respectively). 4)
E and 0 occasionally induced triggered action potentials. Lowering [K]o (5.4
to 4.0 mM) worsened these effects. 5) Without prior AS exposure, E caused
only prolongation of APD and occasionally the induction of early afterdepo-
larizations. Conclusions: E and 0 enhanced DADs and triggered activity. In
the presence of AS induced Ca2+ overload, E and 0 caused shortening of
APD. These effects can not be explained solely by selective block of iKR by E
and D. Additional drug effects, resembling enhancement of cardiac glycoside
toxicity, exist.
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